BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10561095)

  • 1. Surgical strategy for the treatment of medullary thyroid carcinoma.
    Fleming JB; Lee JE; Bouvet M; Schultz PN; Sherman SI; Sellin RV; Friend KE; Burgess MA; Cote GJ; Gagel RF; Evans DB
    Ann Surg; 1999 Nov; 230(5):697-707. PubMed ID: 10561095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
    Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
    G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
    Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
    J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma.
    Dralle H; Damm I; Scheumann GF; Kotzerke J; Kupsch E; Geerlings H; Pichlmayr R
    Surg Today; 1994; 24(2):112-21. PubMed ID: 8054788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing and extension of lymphadenectomy in medullary thyroid carcinoma: A case series from a single institution.
    Polistena A; Sanguinetti A; Lucchini R; Galasse S; Monacelli M; Avenia S; Boccolini A; Johnson LB; Avenia N
    Int J Surg; 2017 May; 41 Suppl 1():S70-S74. PubMed ID: 28506418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
    Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma.
    Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG
    Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients.
    Yen TW; Shapiro SE; Gagel RF; Sherman SI; Lee JE; Evans DB
    Surgery; 2003 Dec; 134(6):890-9; discussion 899-901. PubMed ID: 14668720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of sporadic medullary thyroid cancer.
    Noullet S; Trésallet C; Godiris-Petit G; Hoang C; Leenhardt L; Menegaux F
    J Visc Surg; 2011 Sep; 148(4):e244-9. PubMed ID: 21885365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of sporadic medullary thyroid carcinoma: strategy and outcome.
    Misso C; Calzolari F; Puxeddu E; Lucchini R; Monacelli M; D'Ajello F; Giammartino C; D'Ajello M; Ragusa M; Avenia N
    G Chir; 2008; 29(11-12):475-8. PubMed ID: 19068183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical management and follow-up of medullary thyroid carcinoma.
    Marzano LA; Porcelli A; Biondi B; Lupoli G; Delrio P; Lombardi G; Zarrilli L
    J Surg Oncol; 1995 Jul; 59(3):162-8. PubMed ID: 7609522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?
    Bümming P; Ahlman H; Nilsson B; Nilsson O; Wängberg B; Jansson S
    Langenbecks Arch Surg; 2008 Sep; 393(5):699-703. PubMed ID: 18626656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer.
    Kebebew E; Kikuchi S; Duh QY; Clark OH
    Arch Surg; 2000 Aug; 135(8):895-901. PubMed ID: 10922248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma.
    Gimm O; Ukkat J; Dralle H
    World J Surg; 1998 Jun; 22(6):562-7; discussion 567-8. PubMed ID: 9597929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
    Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
    Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective lateral compartment neck dissection for thyroid cancer.
    Welch K; McHenry CR
    J Surg Res; 2013 Sep; 184(1):193-9. PubMed ID: 23816244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of reoperations for medullary thyroid carcinoma.
    Fialkowski E; DeBenedetti M; Moley J
    World J Surg; 2008 May; 32(5):754-65. PubMed ID: 18188643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
    Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
    Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.